Health Products

pms-Ranitidine 150mg (2020-08-28)

· Published by Health Canada · Official notice

Details

Alert type: Drug Recall
Category: Drugs
Issue: Product Safety
Audience: General Public, Healthcare Professionals, Hospitals
Department: Health Canada
Hazard classification: Type I

Summary

Product

pms-Ranitidine 150mg

Get told about the next health product recall.

We email or text you when Canada issues a recall that matches what you watch: a brand, a product, an allergen. Most never make the news.

Get health product recall alerts

CA$3.99/mo · cancel anytime

Products

Lot or serial numberBrand nameCompaniesDIN, NPN, DIN-HIMDosage formStrength
619003pms-Ranitidine 150mg
Recalling Firm
Pharmascience Inc.
611 ave Royalmount suite 100
Montreal
H4P 2T4
Quebec
CANADA
Marketing Authorization Holder
Pharmascience Inc.
611 ave Royalmount suite 100
Montreal
H4P 2T4
Quebec
CANADA
DIN 02242453TabletRanitidine Hydrochloride 150mg

Reason

Presence of N-nitrosodimethylamine (NDMA) near the interim acceptable concentration limit in affected lot.

Depth of distribution

Wholesalers, Retailers, Healthcare establishments

For more information

Get told about the next health product recall.
Get health product recall alerts

CA$3.99/mo · cancel anytime